These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38401117)

  • 1. Curcumin - Bioavailability Enhancement by Prodrug Approach and Novel Formulations.
    Chelimela N; Alavala RR; Satla SR
    Chem Biodivers; 2024 May; 21(5):e202302030. PubMed ID: 38401117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects.
    Ratnatilaka Na Bhuket P; El-Magboub A; Haworth IS; Rojsitthisak P
    Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):341-353. PubMed ID: 27683187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery.
    Li M; Gao M; Fu Y; Chen C; Meng X; Fan A; Kong D; Wang Z; Zhao Y
    Colloids Surf B Biointerfaces; 2016 Apr; 140():11-18. PubMed ID: 26731193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
    Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin.
    Muangnoi C; Jithavech P; Ratnatilaka Na Bhuket P; Supasena W; Wichitnithad W; Towiwat P; Niwattisaiwong N; Haworth IS; Rojsitthisak P
    Biosci Biotechnol Biochem; 2018 Aug; 82(8):1301-1308. PubMed ID: 29678124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.
    Ipar VS; Dsouza A; Devarajan PV
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):459-480. PubMed ID: 30771095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
    Kharat M; McClements DJ
    J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
    Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
    J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro Permeability and Bioavailability Enhancement of Curcumin by Nanoemulsion via Pulmonary Administration.
    Shi L; Qu Y; Li Z; Fan B; Xu H; Tang J
    Curr Drug Deliv; 2019; 16(8):751-758. PubMed ID: 31722658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on the Pharmacological Usage of Curcumin: Has it Failed in the Drug Discovery Pipeline?
    Olotu F; Agoni C; Soremekun O; Soliman MES
    Cell Biochem Biophys; 2020 Sep; 78(3):267-289. PubMed ID: 32504356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle.
    Hu L; Jia Y; Niu F; Jia Z; Yang X; Jiao K
    J Agric Food Chem; 2012 Jul; 60(29):7137-41. PubMed ID: 22587560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
    Ma Z; Wang N; He H; Tang X
    J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and bioavailability by oral administration of O/W curcumin nanoemulsions stabilized with lysophosphatidylcholine.
    Chávez-Zamudio R; Ochoa-Flores AA; Soto-Rodríguez I; Garcia-Varela R; García HS
    Food Funct; 2017 Sep; 8(9):3346-3354. PubMed ID: 28856361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation.
    Zhang HY; Sun CY; Adu-Frimpong M; Yu JN; Xu XM
    Int J Pharm; 2019 Jan; 555():270-279. PubMed ID: 30471374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocurcumin: a promising therapeutic advancement over native curcumin.
    Flora G; Gupta D; Tiwari A
    Crit Rev Ther Drug Carrier Syst; 2013; 30(4):331-68. PubMed ID: 23662605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of More Efficacious Curcumin Delivery Systems Using Colloid Science: Enhanced Solubility, Stability, and Bioavailability.
    Zheng B; McClements DJ
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks.
    Zhang Y; Rauf Khan A; Fu M; Zhai Y; Ji J; Bobrovskaya L; Zhai G
    J Drug Target; 2019 Nov; 27(9):917-931. PubMed ID: 30672353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.